Nos actualités et évènements
Efficience des équipes et des organisations, la clé de croissance pour votre entreprise !
Efficience ou Efficacité : Serait-ce uniquement une question de sémantique ? L’Efficacité : Remplir le contrat, satisfaire le client, atteindre l’objectif. L’Efficacité ne préjuge en rien de l’ensemble des ressources mobilisées pour obtenir ce résultat. L’Efficience : Mesurer [...]
Pour aller plus loin …
- Akebia Secures $100 Million Non-Dilutive Term Loan Financing; Reports Third Quarter 2019 Financial Results Tuesday, November 12th 2019 at 12:57pm UTC Funding expected to extend Company’s cash runway into 2021, well past its expected...Rédaction
- Sangamo annonce des présentations de données portant sur la thérapie génique et sur la thérapie cellulaire ex vivo à base de gènes modifiés, qui seront données au Congrès annuel de l’American Society of Hematology Thursday, November 7th 2019 at 11:24am UTC BRISBANE, Californie–(BUSINESS WIRE)– Sangamo Therapeutics, Inc. (NASDAQ : SGMO), une société de médecine...Rédaction
- Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination Tuesday, November 12th 2019 at 5:15pm UTC HERTFORDSHIRE, England & PITTSBURGH & NEW YORK–(BUSINESS WIRE)– Mylan N.V. (NASDAQ: MYL) and...Rédaction
- BIOCORP and SANOFI Announce a Partnership to Fit SoloStar Insulin Pens With Mallya Technology Worldwide Thursday, December 12th 2019 at 6:30am UTC ∙ As a first result of the exclusive negotiations initiated in July, the...Rédaction
- Cell-Easy ouvre la voie à la médecine de demain en rendant accessible la thérapie cellulaire Tuesday, December 3rd 2019 at 11:09am UTC TOULOUSE, France–(BUSINESS WIRE)– Cell-Easy annonce une levée de fonds de 1M€ et nomme...Rédaction
- Consistent Effects of FARXIGA in Heart Failure Patients With Reduced Ejection Fraction Shown in New Analyses From Landmark Phase III DAPA-HF Trial Sunday, November 17th 2019 at 3:45pm UTC Data were consistent in patients with and without type 2 diabetes, showed early...Rédaction
- Delta-Fly Pharma, Inc. a lancé l’étude clinique de phase 3 du DFP-10917 et l’étude clinique de phase 1 du DFP-14927 Tuesday, November 26th 2019 at 6:07pm UTC TOKUSHIMA, Japon–(BUSINESS WIRE)– Delta-Fly Pharma, Inc. (TOKYO : 4598) annonce que des patients...Rédaction
- Bioasis Announces Annual General Meeting Results Thursday, December 5th 2019 at 9:05pm UTC GUILFORD, Conn.–(BUSINESS WIRE)– BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a...Rédaction
- Twist Bioscience Promotes Patrick J. Finn, Ph.D., to Chief Commercial Officer Wednesday, November 20th 2019 at 1:00pm UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling...Rédaction
- Global Fluorescent in Situ Hybridization (FISH) Probe Market Size, Share & Trends Analysis Report 2019-2026 – ResearchAndMarkets.com Wednesday, November 13th 2019 at 2:32pm UTC DUBLIN–(BUSINESS WIRE)– The « FISH Probe Market Size, Share & Trends Analysis Report By...Rédaction